Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Inspector General Advises CMS To Monitor Imaging Growth

This article was originally published in The Gray Sheet

Executive Summary

The HHS Office of Inspector General says CMS should keep a close watch on the rapid growth in advanced imaging services at freestanding facilities, but refrains from recommending any actions to curb the growth in a 1report issued Nov. 7

You may also be interested in...



HHS OIG Work Plan: FDA Oversight And DME, Inpatient Payments Make List

The Department of Health and Human Services Office of Inspector General 1outlined Oct. 1 more than 300 new and ongoing investigations on its to-do list for fiscal year 2009, including digging into how Medicare pays for durable medical equipment and examinations of hospital inpatient payments and FDA device oversight

HHS OIG Work Plan: FDA Oversight And DME, Inpatient Payments Make List

The Department of Health and Human Services Office of Inspector General 1outlined Oct. 1 more than 300 new and ongoing investigations on its to-do list for fiscal year 2009, including digging into how Medicare pays for durable medical equipment and examinations of hospital inpatient payments and FDA device oversight

House Cuts Imaging Payments To Help Fund Children’s Health Insurance

The House passed a bill Aug. 1 that would severely cut imaging payments to help pay for expanded coverage for children without health insurance and prevent physician payments from dropping in 2008

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel